Multicell spheroid response to drugs predicted with the comet assay

Cancer Research

Volumn 57, Issue 24, 1997, Pages 5528-5533

  Olive, Peggy L ^a   Banáth, Judit P ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 AZIRIDINO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 4 NITROQUINOLINE 1 OXIDE; CHLORMETHINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; METHYLNITRONITROSOGUANIDINE; TIRAPAZAMINE;

ARTICLE; CANCER CELL CULTURE; CELL KILLING; CELL SURVIVAL; CLONOGENESIS; COLON CARCINOMA; DNA DAMAGE; DRUG RESISTANCE; PRIORITY JOURNAL; SPHEROID CELL;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; CARCINOGENS; CELL DEATH; CELLS, CULTURED; COLONIC NEOPLASMS; CRICETINAE; CRICETULUS; DNA DAMAGE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FIBROBLASTS; HUMANS; LUNG; METHYLNITRONITROSOGUANIDINE; PREDICTIVE VALUE OF TESTS; SPHEROIDS, CELLULAR; UTERINE CERVICAL NEOPLASMS;

EID: 0031454075     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hoffman, R. M. In vitro sensitivity assays in cancer: a review, analysis and prognosis. J. Clin. Lab. Anal., 5: 133-143, 1991.
2. Von Hoff, D. D., Sandbach, J. F., Clark, G. M., Turner, J. N., Forseth, B. F., Piccart, M. J., Colombo, N., and Muggia, F. M. Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J. Natl. Cancer Inst., 82: 82-83, 1990.
3. Christie, N. T., Drake, S., Meyn, R. E., and Nelson, J. A. 6-Thioguanine-induced DNA damage as a determinant of cytotoxicity in cultured Chinese hamster ovary cells. Cancer Res., 44: 3665-3667, 1984.
4. Ducore, J. M., Erickson, L. C., Zwelling, L. A., Laurent, G., and Kohn, K. W. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. Cancer Res., 42: 897-902, 1982.
5. 6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcome. Cancer Res., 54: 4524-4531, 1994.
6. Russo, P., Favoni, R. E., Zarcone, D., Miglietta, L., Peluso, M., Nicolin, A., Bignone, F., and Parodi, S. Doxorubicin cytotoxicity to P388 lymphocytic leukemia as determined by alkaline elution and established assays. Anticancer Res., 6: 1297-1304, 1986.
7. Olive, P. L., Banáth, J. P., and Durand, R. E. Detection of subpopulations resistant to DNA-damaging agents in spheroids and murine tumors. Mutat. Res., 375: 157-165, 1997.
8. Ostling, O., and Johanson, K. J. Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem. Biophys. Res. Commun., 123: 291-298, 1984.
9. Olive, P. L., Banáth, J. P., and Durand, R. E. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat. Res., 122: 69-72, 1990.
10. Fairbairn, D. W., Olive, P. L., and O'Neill, K. L. The comet assay: a comprehensive review. Mutat. Res., 339: 37-59, 1995.
11. McKelvey-Martin, V. M., Green, M. H. L., Schmezer, P., Pool-Zobel, B. L., DeMeo, M. P., and Collins, A. The single cell gel electrophoresis assay (COMET assay): a European review. Mutat. Res., 288: 47-63, 1993.
12. Olive, P. L., Wlodek, D., and Banáth, J. P. DNA double-strand breaks measured in individual cells subjected to gel electrophoresis. Cancer Res., 51: 4671-4676, 1991.
13. Olive, P. L. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to the bioreductive drugs. II. RSU-1069. Br. J. Cancer, 71: 537-542, 1995.
14. Collins, A. R., Duthie, S. J., and Dobson, V. L. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis (Lond.), 14: 1733-1735, 1993.
15. Olive, P. L., Frazer, G., and Banáth, J. P. Radiation-induced apoptosis measured in TK6 human B lymphoblast cells using the comet assay. Radiat. Res., 136: 130-136, 1993.
16. Olive, P. L., and Banáth, J. P. Sizing highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent. Exp. Cell Res., 221: 19-26, 1995.
17. 6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcome. Cancer Res., 54: 4524-4531, 1994.
18. Buschfort, C., Muller, M. R., Seeber, S., Rajewsky, M. F., and Thomale, J. DNA excision repair profiles of normal and leukemic human lymphocytes: functional analysis at the single-cell level. Cancer Res., 57; 651-658, 1997.
19. Tice, R. R., Strauss, G. H., and Peters, W. P. High-dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay. Mutat. Res., 271: 101-113, 1992.
20. Sutherland, R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science (Washington DC), 240: 177-184, 1984.
21. Durand, R. E. The influence of microenvironmental factors on the activity of radiation and drugs. Int. J. Radiat. Oncol. Biol. Phys., 20: 253-258, 1991.
22. Durand, R. E. The influence of microenvironmental factors during cancer therapy. In Vivo, 8: 691-702, 1994.
23. Durand, R. E. Distribution and activity of antineoplastic drugs in a tumor model. J. Natl. Cancer Inst., 81: 146-152, 1989.
24. Olive, P. L., Banáth, J. P., and Evans, H. H. Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: influence of growth environment and DNA packaging. Br. J. Cancer, 67: 522-530, 1993.
25. Olive, P. L. Patterns of mutagen binding and penetration into multicell spheroids. Environ. Mutagen., 8: 705-715, 1986.
26. Olive, P. L., and Banáth, J. P. Growth fraction measured using the comet assay. Cell Prolif., 25: 447-457, 1992.
27. Olive, P. L., and Durand, R. E. Penetration of 4NQO and AF-2 into multicell spheroids. Environ. Mutagen., 5: 553-563, 1983.
28. Brown, J. M. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. Br. J. Cancer. 67: 1163-1170, 1993.
29. Olive, P. L. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine. Br. J. Cancer, 71: 529-536, 1995.
30. Durand, R. E. Flow cytometry studies of intracellular Adriamycin in multicell spheroids in vitro. Cancer Res., 41: 3495-3498, 1981.
31. Roots, R., and Smith, K. C. Effects of actinomycin D on cell cycle kinetics and the DNA of Chinese hamster and mouse mammary tumor cells cultivated in vitro. Cancer Res., 36: 3654-3658, 1976.
32. Olive, P. L. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumors exposed to the bioreductive drugs. II. RSU-1069. Br. J. Cancer, 77: 537-542, 1995.
33. Ward, J. F. Ionizing radiation-induced DNA damage: identities and DNA repair. Basic Life Sci., 38: 135-138, 1986.
34. Speit, G., and Hartmann, A. The contribution of excision repair to the DNA effects seen in the alkaline single cell gel test (comet assay). Mutagenesis, 10: 555-559, 1995.
35. Walker, I. G., and Sridhar, R. The formation and repair of single-strand breaks in DNA of cultured mammalian cells treated with UV-light, methylating agents or 4-nitroquinoline-1-oxide. Chem. Biol. Interact., 12: 229-239, 1976.
36. Olive, P. L., LeRiche, J., and Jackson, S. J. Growth fraction of human tumors: assays and complications. Semin. Radiat. Oncol., 7: 90-98, 1993.
37. Kinsella, A. R., Smith, D., and Pickard, M. Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage. Br. J. Cancer, 75: 935-945, 1997.
38. Huang, P., Olive, P. L., and Durand, R. E. Use of the comet assay for assessment of drug resistance and its modulation in vivo. Br. J. Cancer, in press, 1997.